Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

A search in PubMed revealed that 72 radionuclides have been considered for molecular or
functional targeted radionuclide therapy. As radionuclide therapies increase in number and …

From background physics and biological models to the latest imaging and treatment
modalities, the Handbook of Radiotherapy Physics: Theory and Practice covers all …

Semiconductor quantum dots and nanoparticles composed of metals, lipids or polymers
have emerged with promising applications for early detection and therapy of cancer …

Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …

Background Auger electron emitters that can be targeted into DNA of tumour cells represent
an attractive systemic radiation therapy goal. In the situation of DNA-associated decay, the …

Anaplastic thyroid carcinoma (ATC) is one of the most aggressive human malignancies. The
aggressive behavior of ATC and its resistance to traditional treatment limit the efficacy of …

The development of integrated positron emission tomography (PET)/magnetic resonance
imaging (MRI) scanners opened a new scenario for cancer diagnosis, treatment, and follow …

High-grade gliomas are usually of poor prognosis, and conventional radiotherapy, even
combined with chemotherapy, still fails to improve the survival of patients. Here, we propose …

The review presented here lays out the present state of the art in the field of radionuclide
therapies specifically targeted against the nucleus of cancer cells, focussing on the use of …